Brain levels of the neurotoxic pyridinium metabolite HPP+ and extrapyramidal symptoms in haloperidol-treated mice.

Abstract

The typical antipsychotic haloperidol is a highly effective treatment for schizophrenia but its use is limited by a number of serious, and often irreversible, motor side effects. These adverse drug reactions, termed extrapyramidal syndromes (EPS), result from an unknown pathophysiological mechanism. One theory relates to the observation that the haloperidol metabolite HPP+ (4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-pyridinium) is structurally similar to MPP+ (1-methyl-4-phenylpyridinium), a neurotoxin responsible for an irreversible neurodegenerative condition similar to Parkinson's disease. To determine whether HPP+ contributes to haloperidol-induced EPS, we measured brain HPP+ and haloperidol levels in strains of mice at high (C57BL/6J and NZO/HILtJ) and low (BALB/cByJ and PWK/PhJ) liability to haloperidol-induced EPS following chronic treatment (7-10 adult male mice per strain). Brain levels of HPP+ and the ratio of HPP+ to haloperidol were not significantly different between the haloperidol-sensitive and haloperidol-resistant strain groups (P=0.50). Within each group, however, strain differences were seen (P<0.01), indicating that genetic variation regulating steady-state HPP+ levels exists. Since the HPP+ levels that we observed in mouse brain overlap the range of those detected in post-mortem human brains following chronic haloperidol treatment, the findings from this study are physiologically relevant to humans. The results suggest that strain differences in steady-state HPP+ levels do not explain sensitivity to haloperidol-induced EPS in the mice we studied.

• Authors: James J Crowley, Mehdi Ashraf-Khorassani, Neal Castagnoli Jr, Patrick F Sullivan
• Journal: Neurotoxicology (Neurotoxicology) Vol. 39 Pg. 153-7 (Dec 2013) ISSN: 1872-9711 [Electronic] Netherlands
• PMID: 24107597 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
• Copyright: Copyright © 2013 Elsevier Inc. All rights reserved.

Chemical References

• Antipsychotic Agents
• Phenols
• Propanols
• 3-(4-hydroxyphenyl)propanol
• Haloperidol

Topics

• Animals
• Antipsychotic Agents (toxicity)
• Basal Ganglia Diseases (chemically induced, physiopathology)
• Brain (drug effects, metabolism)
• Chromatography, Liquid
• Disease Models, Animal
• Haloperidol (toxicity)
• Male
• Mastication (drug effects)
• Mice
• Mice, Inbred C57BL
• Phenols (chemistry, metabolism)
• Propanols (chemistry, metabolism)
• Species Specificity
• Statistics, Nonparametric
• Tandem Mass Spectrometry